Repurposed flu medicine could help under 60s recover faster from COVID-19
Results of an international repurposing study show favipiravir could help with COVID-19.
Results of an international repurposing study show favipiravir could help with COVID-19.
Welcome to Anna Tomlinson, who joins LifeArc as our first Chief Communications Officer.
LifeArc played an important part in the discovery of lecanemab, an experimental drug that has shown some benefits for people with early Alzheimer’s disease.
The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.
AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS
Researchers can now apply for funding to progress exciting gene therapy research.
The toolkit helps researchers, charities and others navigate the opportunities and challenges of repurposing medicines.
LifeArc scientist Finbar Gaffey awarded a coveted industrial fellowship from the Royal Commission for the Exhibition of 1851.
It is with deep sadness that we share the news that Aisling Burnand CBE passed away on Monday 19 September 2022.